Von Willebrand's disease and angiodysplasia treated with thalidomide

被引:27
作者
Hirri, HM [1 ]
Green, PJ
Lindsay, J
机构
[1] Portsmouth Hosp NHS Trust, London, England
[2] London NHS Trust, London, England
关键词
Angiodysplasia; Gastrointestinal Bleeding; Thalidomide; Von Willebrand's disease;
D O I
10.1111/j.1365-2516.2006.01210.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 54-year-old man with type IIB VWD and severe angiodysplasia had such a large blood loss from the bowel that it was difficult to keep up with transfusion requirements. Treatment with factor eight concentrate barely slowed the loss. D.D.A.V.P., Octreotide, and recombinant activated Factor VII, tried separately, were ineffective. The use of Thalidomide at a dose of 150 mg daily has rendered him free from blood loss for the last six months and we suggest would be worth a trial in similar cases.
引用
收藏
页码:285 / 286
页数:2
相关论文
共 5 条
[1]   Thalidomide for treatment of severe intestinal bleeding [J].
Bauditz, J ;
Schachschal, G ;
Wedel, S ;
Lochs, H .
GUT, 2004, 53 (04) :609-612
[2]   Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's disease [J].
Bowers, M ;
McNulty, O ;
Mayne, E .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (03) :524-527
[3]   The use of wireless capsule endoscopy to detect small bowel angiodysplasia in a patient with obscure gastrointestinal bleeding and von Willebrand disease [J].
Lecleire, S ;
Di Fiore, F ;
Ben Soussan, E ;
Borg, JY ;
Antonietti, M ;
Lerebours, E .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (01) :115-116
[4]   Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand's disease, controlled with recombinant factor VIIa [J].
Meijer, K ;
Peters, FTM ;
van der Meer, J .
BLOOD COAGULATION & FIBRINOLYSIS, 2001, 12 (03) :211-213
[5]  
Shurafa M, 2003, AM J GASTROENTEROL, V98, P221